Lanzamiento Enero 2027

Ensayo controlado aleatorizado2000

Oral magnesium therapy improves endothelial function in patients with coronary artery disease

Shechter M, Sharir M, Labrador MJ, Forrester J, Silver B, Bairey Merz CN

Circulation · 176 citas

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación independiente
Universidad u hospital
Cedars-Sinai Medical Center

Según 1 financiador declarado.

Publicación

Publicado
2000-11-07 · Circulation · vol. 102 · número 19 · págs. 2353–2358
Editorial
Lippincott Williams & Wilkins
Citado
298 citas · más que el 98% de estudios similares · 8.4× el promedio de su campo
Impacto
Entre el 10 % más citado de su campo
Referencias
37 trabajos
Acceso
Lectura gratuita
Áreas de investigación
Magnesium in Health and Disease · Cardiovascular Health and Disease Prevention · Nitric Oxide and Endothelin Effects
Palabras clave
oral magnesium supplementation, coronary artery disease, endothelial function, flow-mediated dilation, intracellular magnesium, exercise tolerance, exercise stress testing, ST-segment changes, brachial artery
MeSH
brachial artery, endothelium, vascular, humans, coronary disease, magnesium, placebos, treatment outcome, administration, oral, double-blind method, vasodilation, exercise tolerance, adult, aged, middle aged, female, male

6 autores

  • Michael Shechter🇺🇸Cedars-Sinai Medical Center; University of California, Los Angeles
  • Michael Sharir🇺🇸Cedars-Sinai Medical Center; University of California, Los Angeles
  • Maura J. Paul-Labrador🇺🇸Cedars-Sinai Medical Center; University of California, Los Angeles
  • James S. Forrester🇺🇸Cedars-Sinai Medical Center; University of California, Los Angeles
  • Burton B. Silver🇺🇸Cedars-Sinai Medical Center; University of California, Los Angeles
  • C. Noel Bairey Merz🇺🇸Cedars-Sinai Medical Center; University of California, Los Angeles

Resumen

El texto original del estudio, en el idioma en que se publicó.

Background

Magnesium blocks many of the physiological actions of calcium. Nevertheless, the impact of magnesium supplementation on endothelial function and exercise tolerance in stable coronary artery disease (CAD) patients has not been assessed.

Methods and results

In a randomized, double-blind, placebo-controlled trial, 50 stable CAD patients (41 men and 9 women, mean+/-SD age 67+/-11 years, age range 42 to 82 years) were randomized to receive either magnesium (n=25) (30 mmol/d Magnosolv-Granulat; Asta Medica Company, Inc) or placebo (n=25) for 6 months. Before and after 6 months, endothelium-dependent brachial artery flow-mediated vasodilation (FMD) and endothelium-independent NTG-mediated vasodilation were assessed with high-resolution (10-MHz) ultrasound. Exercise stress testing was performed with use of the Bruce protocol. Intracellular magnesium concentrations ([Mg(2+)](i)) were assessed from sublingual cells through x-ray dispersion (EXA) (normal mean+/-SD values 37. 9+/-4.0 mEq/L). The magnesium therapy significantly increased postintervention ([Mg(2+)](i) versus placebo (36.2+/-5.0 versus 32.7+/-2.7 mEq/L, P<0.02). There was a significant correlation in the total population between baseline [Mg(2+)](i) and baseline FMD (r=0. 48, P<0.01). The magnesium intervention resulted in a significant improvement in postintervention FMD (15.5+/-12.0%, P=0.02 compared with baseline), which was not evident with placebo (4.4+/-2.5%, P=0.78 compared with baseline). There was better exercise tolerance (9.3+/-2.0 versus 7.3+/-3.1 minutes, P=0.05) and less ischemic ST-segment changes (4 versus 10 patients, P=0.05) in the magnesium versus placebo groups, respectively.

Conclusions

Oral magnesium therapy in CAD patients is associated with significant improvement in brachial artery endothelial function and exercise tolerance, suggesting a potential mechanism by which magnesium could beneficially alter outcomes in CAD patients.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.